This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
CRYBA4 Polyclonal Antibody
catalog :
PA5-22032
quantity :
100 uL
price :
US 470.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunocytochemistry
product information
Product Type :
Antibody
Product Name :
CRYBA4 Polyclonal Antibody
Catalog # :
PA5-22032
Quantity :
100 uL
Price :
US 470.00
Clonality :
Polyclonal
Purity :
Antigen affinity chromatography
Host :
Rabbit
Reactivity :
Human, Mouse
Applications :
Immunocytochemistry: 1:100-1:1,000, Western Blot: 1:500-1:3,000
Species :
Human, Mouse
Isotype :
IgG
Storage :
Store at 4 C short term. For long term storage, store at -20 C, avoiding freeze/thaw cycles.
Description :
Crystallins are the dominant structural components of the vertebrate eye lens.
Immunogen :
Recombinant fragment corresponding to a region within amino acids 1 and 196 of beta A4 Crystallin (Uniprot ID#P53673)
Format :
Liquid
Applications w/Dilutions :
Immunocytochemistry: 1:100-1:1,000, Western Blot: 1:500-1:3,000
Aliases :
beta crystallin A4 chain transcript PS; beta crystallin alpha 4 chain; beta-A4 crystallin; Beta-crystallin A4; Cryba4; crystallin beta A4; crystallin, beta A4; crystallin, beta polypeptide A4; CTA-445C9.1; CTRCT23; CYRBA4; eye lens structural protein; MCOPCT4
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments
